Citation: Wr. Lance, NEW PHARMACEUTICALS FOR USE IN WILD AND EXOTIC SPECIES BEYOND 2000 - THE CHALLENGES FOR INDUSTRY AND FDA, Veterinary and human toxicology, 40, 1998, pp. 22-23
Citation: Mw. Miller et al., EFFICACY AND SAFETY OF NALTREXONE HYDROCHLORIDE FOR ANTAGONIZING CARFENTANIL CITRATE IMMOBILIZATION IN CAPTIVE ROCKY-MOUNTAIN ELK (CERVUS-ELAPHUS NELSONI), Journal of wildlife diseases, 32(2), 1996, pp. 234-239
Citation: Wr. Lance, EXTRALABEL DRUG-USE - THE LIFEBLOOD OF ZOO ANIMAL AND WILDLIFE MEDICINE, Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1649-1650
Authors:
LOEW FM
WELSER J
LANCE WR
FRANCISFLOYD R
JOHNSON DE
CLELAND J
TESKE R
RITTER L
MORIN MJ
GLOYD J
MACOMBER E
LEIN D
SOJKA NJ
LAUTNER B
REID J
Citation: Fm. Loew et al., USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .2., Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1654-1658